NURS 6521 / NURS6521 ADVANCED PHARMACOLOGY MIDTERM EXAM PREP
NEWEST 2026/2027 ACTUAL EXAM COMPLETE QUESTIONS AND CORRECT
DETAILED ANSWERS (VERIFIED ANSWERS) WITH DETAILED RATIONALES
|ALREADY GRADED A+||BRAND NEW VERSION!!
DESCRIPTION
This NURS6521 Advanced Pharmacology Midterm Exam tests your ability to safely
prescribe by mastering pharmacokinetics, the Autonomic Nervous System, and
multi-system drug management. You will be evaluated on your proficiency in
treating complex Cardiovascular and Respiratory conditions while navigating the
high-stakes risks of anticoagulation therapy. The exam further assesses your skill in
managing Endocrine, Gastrointestinal, and Pain regimens, ensuring patient safety
across diverse populations. You must also demonstrate competence in selecting
precise Anti-infective agents while mitigating dangerous drug-drug interactions
and side effects. Ultimately, this midterm validates your readiness to exercise
clinical judgment and prescriptive authority in an advanced practice nursing role.
Contents Covered
Chapter 1: Pharmacokinetics, Pharmacodynamics, and Principles of Drug Therapy2
Chapter 2: The Autonomic Nervous System (ANS) ............................................... 12
Chapter 3: Cardiovascular Pharmacology ............................................................. 23
Chapter 4: Respiratory and Hematologic Pharmacology ...................................... 34
Chapter 5: Endocrine and Gastrointestinal Pharmacology ................................... 45
Chapter 6: Anti-infectives, Pain, and Inflammation .............................................. 55
1|Page
, NURS 6521 / NURS6521 Advanced Pharmacology Midterm Exam Prep
Chapter 1: Pharmacokinetics, Pharmacodynamics,
and Principles of Drug Therapy
Topics: Absorption, Distribution, Metabolism, Excretion (ADME), Half-life,
Agonists/Antagonists, and Lifespan Considerations.
1. A patient with end-stage renal disease is prescribed a drug that is primarily
excreted by the kidneys. The nurse practitioner (NP) understands that this patient
is at risk for:
a) Reduced therapeutic effect
b) Increased drug toxicity
c) Rapid first-pass metabolism
d) Enhanced drug distribution
Correct Answer: b) Increased drug toxicity
Rationale: When renal function is impaired, the body cannot effectively clear
drugs excreted via the kidneys. This leads to an accumulation of the drug in the
bloodstream, significantly increasing the risk of toxicity.
2. An elderly patient is taking a lipid-soluble medication. The NP knows that age-
related changes in body composition (increased body fat) will likely cause the
drug's half-life to:
a) Decrease significantly
b) Remain unchanged
c) Increase
2|Page
, NURS 6521 / NURS6521 Advanced Pharmacology Midterm Exam Prep
d) Result in faster excretion
Correct Answer: c) Increase
Rationale: Lipid-soluble drugs are distributed into fatty tissues. As body fat
increases with age, the volume of distribution for these drugs increases, leading to
a prolonged half-life and longer duration of action.
3. When considering the "First-Pass Effect," which route of administration is most
affected by hepatic metabolism before reaching systemic circulation?
a) Intravenous (IV)
b) Sublingual
c) Transdermal
d) Oral
Correct Answer: d) Oral
Rationale: Oral medications are absorbed in the GI tract and carried directly to the
liver via the portal vein. The liver metabolizes a portion of the drug before it ever
reaches the rest of the body. IV, sublingual, and transdermal routes bypass this
initial hepatic pass.
4. A patient is prescribed a drug that is a "Prodrug." The NP explains to the patient
that this means:
a) The drug is active immediately upon ingestion.
b) The drug is inactive until it is metabolized by the liver.
c) The drug is highly toxic to the liver.
d) The drug bypasses the liver entirely.
Correct Answer: b) The drug is inactive until it is metabolized by the liver.
3|Page
, NURS 6521 / NURS6521 Advanced Pharmacology Midterm Exam Prep
Rationale: Prodrugs are pharmacologically inactive compounds that require
metabolic conversion (usually by liver enzymes) to become active, functional
metabolites.
5. A patient is taking a drug with a narrow therapeutic index. Which action is most
important for the NP to take?
a) Increase the dose to ensure efficacy.
b) Monitor serum drug levels frequently.
c) Switch the patient to a generic version immediately.
d) Advise the patient to take the drug only when they feel symptoms.
Correct Answer: b) Monitor serum drug levels frequently.
Rationale: A narrow therapeutic index means there is a very small margin
between a therapeutic dose and a toxic dose. Close monitoring is essential to
prevent adverse effects.
6. A nursing mother asks about the safety of taking a Category X medication. What
is the most appropriate response?
a) "It is safe as long as you wait 4 hours before breastfeeding."
b) "It is only dangerous in the first trimester."
c) "This drug is contraindicated because it poses a high risk of fetal abnormalities."
d) "You can take it, but only at half the recommended dose."
Correct Answer: c) This drug is contraindicated because it poses a high risk of fetal
abnormalities.
Rationale: Under the older FDA categories (still often tested), Category X drugs
have demonstrated human fetal abnormalities and the risks clearly outweigh any
potential benefits.
4|Page